# Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults

> **NCT00435968** · PHASE2 · COMPLETED · sponsor: **CV Technologies** · enrollment: 50 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CVT E002 (Cold-fX)

## Key facts

- **NCT ID:** NCT00435968
- **Lead sponsor:** CV Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2007-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435968, "Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00435968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*